Detalhe da pesquisa
1.
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Ann Oncol
; 34(10): 920-933, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704166
2.
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.
Ann Oncol
; 28(5): 1078-1083, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327934
3.
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program.
Ann Oncol
; 28(11): 2715-2724, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945865
4.
Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors.
Lung Cancer
; 182: 107280, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339550
5.
[Management of immunotherapy in patients with non-small cell lung cancer presenting durable oncological response]. / Prescription de l'immunothérapie chez les patients « long-répondeurs ¼.
Rev Mal Respir
; 39(7): 578-586, 2022 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-35909007
6.
[French practical guidelines for the diagnosis and management of IPF - 2021 update, short version]. / Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique Actualisation 2021. Version courte.
Rev Mal Respir
; 39(3): 275-312, 2022 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-35304014
7.
[French practical guidelines for the diagnosis and management of IPF - 2021 update, full version]. / Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique Actualisation 2021. Version intégrale.
Rev Mal Respir
; 39(7): e35-e106, 2022 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-35752506
8.
[Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020]. / Guide de prise en charge des séquelles respiratoires post infection à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de Pneumologie de Langue Française. Version du 10 novembre 2020.
Rev Mal Respir
; 38(1): 114-121, 2021 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-33280941
9.
Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study.
Respir Med Res
; 80: 100795, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242973
10.
[Severe adult asthma and treatment adherence: Results of the FASE-CPHG study]. / Asthme sévère de l'adulte et observance : résultats de l'étude FASE-CPHG.
Rev Mal Respir
; 38(10): 962-971, 2021 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-34649732
11.
Management of lung cancer patients' quality of life in clinical practice: a Delphi study.
ESMO Open
; 6(4): 100239, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388690
12.
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.
Lung Cancer
; 151: 69-75, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248711
13.
[Cerebral air embolism: A rare complication of flexible fiberoptic bronchoscopy]. / Embolie gazeuse cérébrale : une complication rare de la fibroscopie bronchique souple.
Rev Mal Respir
; 37(8): 662-665, 2020 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-32863066
14.
Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients.
Respir Med Res
; 77: 46-54, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036284
15.
[Physical activity in severe asthma: Results of the FASE-CPHG Study]. / Activité physique et asthme sévère : résultats de l'étude FASE-CPHG.
Rev Mal Respir
; 37(4): 320-327, 2020 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-32276745
16.
[Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020]. / Guide pour le suivi respiratoire des patients ayant présenté une pneumonie à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de pneumologie de langue française. Version du 10 mai 2020.
Rev Mal Respir
; 37(6): 505-510, 2020 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-32410773
17.
Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survival.
Respir Med Res
; 76: 38-44, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527016
18.
[Second- or third-line treatment with erlotinib in EGFR wild-type non-small cell lung cancer: Real-life data]. / Erlotinib en 2e ou 3e ligne pour les cancers bronchiques non à petites cellules sans mutation de l'EGFR : données en vie réelle.
Rev Mal Respir
; 36(6): 649-663, 2019 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-31204231
19.
[How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study]. / Comment traiter la rechute du CBNPC après une chirurgie et chimiothérapie?
Rev Mal Respir
; 25(1): 91-6, 2008 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-18288059
20.
[What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?]. / Quel traitement pour un patient de PS-2/3 ayant un cancer bronchique non à petites cellules (CBNPC) de stade IV?
Rev Mal Respir
; 24(8 Pt 2): 6S120-4, 2007 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-18235404